Great Leadership By Dan

JUNE 14, 2018

When does pharmaceutical pricing become price gouging? Employees and managers in the autonomy stage are ready for mature leadership. Those in the ideological stage may have charisma but are best avoided when top leadership responsibilities are assigned. When does online data harvesting become invasion of privacy?

Ethics 197

Ethics Maturity Analysis Cost-Benefit Analysis 197

The Practical Leader

APRIL 6, 2022

Many more people are searching beyond a job or career to find a calling. ” These shifts have profound implications for leadership and culture. ” Pharmaceutical company: “ Preserving and improving human life.” Creating leadership energy is an inside job. We want to make a difference.

Mintzberg 111

Mintzberg Pharmaceuticals Energy McKinsey 111

Leading Blog

AUGUST 14, 2018

The stories are absorbing and alone are worth the price of the book.) Yu examines pharmaceutical companies like Novartis and the soap company P&G to see how they moved across knowledge disciplines to leverage or create new knowledge on how their product was made. Corporate leaders need to absorb career risks….

How To 165

How To Core Competence Pharmaceuticals Creativity 165

Marshall Goldsmith

FEBRUARY 8, 2018

Jim Kim (President of the World Bank), Peter Drucker (founder of modern management), Paul Hersey (noted author, teacher, and personal mentor of mine), and Warren Bennis (one of the world’s greatest leadership thinkers of his time). Has been recognized as the World’s #1 Leadership Thinker. Author of two best-selling leadership books.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Harvard Business Review

SEPTEMBER 4, 2015

However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. We found that, for pharmaceutical industry CEOs, there is a statistically significant relationship between a CEO’s specialist background and the firm’s performance.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

MARCH 14, 2017

Year-on-year price increases for existing therapies have allowed the industry to maintain profitability, but those short-term fixes have come at a heavy cost: decreased public satisfaction with the industry and increased political scrutiny. Food and Drug Administration (FDA), the lowest number since 2007.

Innovation 8

Innovation Company Incentives Industry 8